Carbamazepine Tablet, Extended Release
Product Images NDC 0832-6022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0832-6022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Carbamazepine extended-release tablets are available in a 100mg dose form. The recommended dosage should be obtained from the Prescribing Information. The tablets are packaged in a light-resistant container with a child-resistant closure, and should be stored between 15°C to 30°C. The manufacturer is CSPC Ouyl Phamnaceutc Go, Li. The tablets must be swallowed whole and never crushed or chewed.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Each extended-release tablet contains 200 mg of Carbamazepine, USP. It is recommended to follow the prescribing information for usual dosage. The tablets must be stored at a temperature of 25°C (77°F) with excursions permitted from 15° to 30°C (59° to 86°F). It should be protected from moisture and kept in a tight, light-resistant container with a child-resistant closure. These extended-release tablets should not be crushed or chewed. A Medication Guide provided separately should be dispensed to each patient. This pack is child-resistant, and it's important to keep out of reach of children.*
FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
This is a description of carbamazepine extended-release tablets. Each tablet contains 400 mg of carbamazepine. The usual dosage is in the prescribing information. The tablets should be stored at a temperature range of 15°C to 30°C and protected from moisture. The tablets should be kept out of reach of children. Manufactured by CSPC Onyi Pharmaceuticals Co, Ltd., and distributed by Upsher-Smith Laboratories. The medication guide should be provided separately to each patient. The tablets should be swallowed whole and not crushed or chewed. This pack contains 100 tablets and is available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.